348 related articles for article (PubMed ID: 19914449)
1. Adeno-associated viral vectors and their redirection to cell-type specific receptors.
Michelfelder S; Trepel M
Adv Genet; 2009; 67():29-60. PubMed ID: 19914449
[TBL] [Abstract][Full Text] [Related]
2. Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism.
Wu P; Xiao W; Conlon T; Hughes J; Agbandje-McKenna M; Ferkol T; Flotte T; Muzyczka N
J Virol; 2000 Sep; 74(18):8635-47. PubMed ID: 10954565
[TBL] [Abstract][Full Text] [Related]
3. Vector Affinity and Receptor Distribution Define Tissue-Specific Targeting in an Engineered AAV Capsid.
Martino RA; Wang Q; Xu H; Hu G; Bell P; Arroyo EJ; Sims JJ; Wilson JM
J Virol; 2023 Jun; 97(6):e0017423. PubMed ID: 37199615
[TBL] [Abstract][Full Text] [Related]
4. Successful expansion but not complete restriction of tropism of adeno-associated virus by in vivo biopanning of random virus display peptide libraries.
Michelfelder S; Kohlschütter J; Skorupa A; Pfennings S; Müller O; Kleinschmidt JA; Trepel M
PLoS One; 2009; 4(4):e5122. PubMed ID: 19357785
[TBL] [Abstract][Full Text] [Related]
5. Controlling AAV Tropism in the Nervous System with Natural and Engineered Capsids.
Castle MJ; Turunen HT; Vandenberghe LH; Wolfe JH
Methods Mol Biol; 2016; 1382():133-49. PubMed ID: 26611584
[TBL] [Abstract][Full Text] [Related]
6. Directed evolution of adeno-associated virus (AAV) as vector for muscle gene therapy.
Yang L; Li J; Xiao X
Methods Mol Biol; 2011; 709():127-39. PubMed ID: 21194025
[TBL] [Abstract][Full Text] [Related]
7. Novel random peptide libraries displayed on AAV serotype 9 for selection of endothelial cell-directed gene transfer vectors.
Varadi K; Michelfelder S; Korff T; Hecker M; Trepel M; Katus HA; Kleinschmidt JA; Müller OJ
Gene Ther; 2012 Aug; 19(8):800-9. PubMed ID: 21956692
[TBL] [Abstract][Full Text] [Related]
8. Engineering and evolution of synthetic adeno-associated virus (AAV) gene therapy vectors via DNA family shuffling.
Kienle E; Senís E; Börner K; Niopek D; Wiedtke E; Grosse S; Grimm D
J Vis Exp; 2012 Apr; (62):. PubMed ID: 22491297
[TBL] [Abstract][Full Text] [Related]
9. Peptide ligands incorporated into the threefold spike capsid domain to re-direct gene transduction of AAV8 and AAV9 in vivo.
Michelfelder S; Varadi K; Raupp C; Hunger A; Körbelin J; Pahrmann C; Schrepfer S; Müller OJ; Kleinschmidt JA; Trepel M
PLoS One; 2011; 6(8):e23101. PubMed ID: 21850255
[TBL] [Abstract][Full Text] [Related]
10. How to Successfully Screen Random Adeno-Associated Virus Display Peptide Libraries In Vivo.
Körbelin J; Trepel M
Hum Gene Ther Methods; 2017 Jun; 28(3):109-123. PubMed ID: 28193101
[TBL] [Abstract][Full Text] [Related]
11. Expressing Transgenes That Exceed the Packaging Capacity of Adeno-Associated Virus Capsids.
Chamberlain K; Riyad JM; Weber T
Hum Gene Ther Methods; 2016 Feb; 27(1):1-12. PubMed ID: 26757051
[TBL] [Abstract][Full Text] [Related]
12. Designer gene delivery vectors: molecular engineering and evolution of adeno-associated viral vectors for enhanced gene transfer.
Kwon I; Schaffer DV
Pharm Res; 2008 Mar; 25(3):489-99. PubMed ID: 17763830
[TBL] [Abstract][Full Text] [Related]
13. Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors.
Shi W; Arnold GS; Bartlett JS
Hum Gene Ther; 2001 Sep; 12(14):1697-711. PubMed ID: 11560765
[TBL] [Abstract][Full Text] [Related]
14. The role of the adeno-associated virus capsid in gene transfer.
Van Vliet KM; Blouin V; Brument N; Agbandje-McKenna M; Snyder RO
Methods Mol Biol; 2008; 437():51-91. PubMed ID: 18369962
[TBL] [Abstract][Full Text] [Related]
15. Ocular Inflammatory Response to Intravitreal Injection of Adeno-Associated Virus Vector: Relative Contribution of Genome and Capsid.
Timmers AM; Newmark JA; Turunen HT; Farivar T; Liu J; Song C; Ye GJ; Pennock S; Gaskin C; Knop DR; Shearman MS
Hum Gene Ther; 2020 Jan; 31(1-2):80-89. PubMed ID: 31544533
[TBL] [Abstract][Full Text] [Related]
16. An Alternate Route for Adeno-associated Virus (AAV) Entry Independent of AAV Receptor.
Dudek AM; Pillay S; Puschnik AS; Nagamine CM; Cheng F; Qiu J; Carette JE; Vandenberghe LH
J Virol; 2018 Apr; 92(7):. PubMed ID: 29343568
[TBL] [Abstract][Full Text] [Related]
17. Optimization of design and production strategies for novel adeno-associated viral display peptide libraries.
Körbelin J; Hunger A; Alawi M; Sieber T; Binder M; Trepel M
Gene Ther; 2017 Aug; 24(8):470-481. PubMed ID: 28622288
[TBL] [Abstract][Full Text] [Related]
18. Impact of capsid modifications by selected peptide ligands on recombinant adeno-associated virus serotype 2-mediated gene transduction.
Naumer M; Popa-Wagner R; Kleinschmidt JA
J Gen Virol; 2012 Oct; 93(Pt 10):2131-2141. PubMed ID: 22764318
[TBL] [Abstract][Full Text] [Related]
19. A myocardium tropic adeno-associated virus (AAV) evolved by DNA shuffling and in vivo selection.
Yang L; Jiang J; Drouin LM; Agbandje-McKenna M; Chen C; Qiao C; Pu D; Hu X; Wang DZ; Li J; Xiao X
Proc Natl Acad Sci U S A; 2009 Mar; 106(10):3946-51. PubMed ID: 19234115
[TBL] [Abstract][Full Text] [Related]
20. Comparison of gene transfer to the murine liver following intraperitoneal and intraportal delivery of hepatotropic AAV pseudo-serotypes.
Dane AP; Wowro SJ; Cunningham SC; Alexander IE
Gene Ther; 2013 Apr; 20(4):460-4. PubMed ID: 22895507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
